Welcome to LookChem.com Sign In|Join Free

CAS

  • or

27489-62-9

Post Buying Request

27489-62-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

27489-62-9 Usage

Description

Trans-4-Aminocyclohexanol is also named as Cis-4-Aminocyclohexanol. It was a medical intermediate of ambroxol, which is used in the treatment of respiratory diseases associated with viscid or excessive mucus.1 It is used as a raw material in organic synthesis, such as in the synthesis of N-substituted 7-azabicyclo [2.2.1] hepatanes, which are good substrates for microbial oxidation of unactivated carbons by B.bassiana.2

Reference

Y. Jian, Improved Process of the Synthesis of Trans-4-aminocyclohexanol, Fine Chemicals, 2000, vol. 2 H. F. Olivo, M. S. Hemenway, M. H. Gezginci, Synthesis and Microbial Hydroxylation of Some Azabicycloalkanes, Tetrahedron Letters, 1998, vol. 39, pp. 1309-1312

Chemical Properties

white to light yellow crystal powder

Uses

Different sources of media describe the Uses of 27489-62-9 differently. You can refer to the following data:
1. trans-4-aminocyclohexanol be used as organic intermediates.
2. trans-4-Aminocyclohexanol is used as raw material in organic synthesis and is an important intermediate in the synthesis of drugs such as Ambroxol hydrochloride. It can react with butyric acid-(2-chloro-ethyl ester) to get butyric acid 4-amino-cyclohexyl ester. This reaction needs catalytic agent Aspergillus niger lipase and solvent 2-methyl-butan-2-ol.

Check Digit Verification of cas no

The CAS Registry Mumber 27489-62-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,4,8 and 9 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 27489-62:
(7*2)+(6*7)+(5*4)+(4*8)+(3*9)+(2*6)+(1*2)=149
149 % 10 = 9
So 27489-62-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO/c7-5-1-3-6(8)4-2-5/h5-6,8H,1-4,7H2/t5-,6+

27489-62-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (B22365)  trans-4-Aminocyclohexanol, 98+%   

  • 27489-62-9

  • 5g

  • 237.0CNY

  • Detail
  • Alfa Aesar

  • (B22365)  trans-4-Aminocyclohexanol, 98+%   

  • 27489-62-9

  • 25g

  • 894.0CNY

  • Detail
  • Alfa Aesar

  • (B22365)  trans-4-Aminocyclohexanol, 98+%   

  • 27489-62-9

  • 100g

  • 1625.0CNY

  • Detail

27489-62-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name trans-4-Aminocyclohexanol

1.2 Other means of identification

Product number -
Other names 1,4-trans-hydroxycyclohexylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:27489-62-9 SDS

27489-62-9Relevant articles and documents

Method for recovering trans - P-aminocyclohexanol by low-concentration waste liquid

-

Paragraph 0044-0068, (2021/09/21)

The invention relates to the technical field of medical chemical raw material recycling, and particularly discloses a method for recovering trans -amino cyclohexanol from low-concentration waste liquid. The method comprises the following steps: adjusting the waste liquor to alkalinity, adding benzaldehyde and stirring, filtering and drying to obtain trans -4 - (benzylidene - amino) - cyclohexanol. The trans -4 - (benzylidene - amino) - cyclohexanol was added to a sulfuric acid solution, and after stirring, the liquid was left standing to obtain trans - p-aminocyclohexanol sulfate aqueous solution. After stirring and decoloring, the alkali content of the filtrate is adjusted to - and after the reaction is stirred, the oil layer is left to stand, and extraction, concentration and purification of the extractant are added to the oil layer to obtain trans 10 - 25% -amino cyclohexanol. To the method, waste liquid discharged in industrial synthesis of ambroxol hydrochloride and alkali waste liquid generated by trans -amino cyclohexanol can be produced, and trans -amino cyclohexanol can be recycled.

A process for preparing trans to amino cyclohexanol

-

Paragraph 0020-0035, (2019/07/11)

The invention discloses a process for preparing trans to amino cyclohexanol, the method takes the aminophenol as raw material, adding metal catalyst, in order to carbonate or sulfate as an additive, in the ketone solvent in the judgement of the hydrogenation reaction to obtain the amino cyclohexanol, then post-processed to obtain trans to amino cyclohexanol. The invention uses relatively inexpensive to amino phenol, to replace the more expensive acetaminophen, the production cost is reduced, and improves the economic benefit, and exploration by the experiment, it was found that the reaction of the preparation process is relatively gentle, the reaction temperature and the reaction pressure is greatly reduced, it is easy to operate, is suitable for industrial production. Reaction of the resulting product yield can reach 80 - 90%, a high proportion of trans to amino cyclohexanol, small pollution to the environment.

ISOTOPE ENHANCED AMBROXOL FOR LONG LASTING AUTOPHAGY INDUCTION

-

Page/Page column 21-22, (2018/09/08)

The present invention is directed to 13C and/or 2H isotope enhanced ambroxol ("isotope enhanced ambroxol") and its use in the treatment of autophagy infections, especially mycobacterial and other infections, disease states and/or conditions of the lung, such as tuberculosis, especially including drug resistant and multiple drag resistant tuberculosis. Pharmaceutical compositions comprising isotope enhanced amhroxol, alone or in combination with an additional bioactive agent, especially rifamycin antibiotics, including an additional autophagy modulator (an agent which is active to promote or inhibit autophagy), thus being useful against, an autophagy mediated disease state and/or condition), especially an antophagy mediated disease state and/or condition which occurs in the lungs, for example, a Mycobacterium infection. Chronic Obstructive Pulmonary Disease (COPD), asthma, pulmonary fibrosis, cystic fibrosis, Sjogren's disease and lung cancer (small cell and non-small cell lung cancer, among other disease states and/or conditions, especially of the lung. Methods of treating autophagy disease states and/or conditions, especially including autophagy disease states or conditions which occur principally in the lungs of a patient represent a further embodiment of the present invention. An additional embodiment includes methods of synthesizing compounds according to the present invention as otherwise disclosed herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 27489-62-9